Investigating Inhibitory Control Networks in Parkinson's Disease — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Investigating Inhibitory Control Networks in Parkinson's Disease — Stella

Recruiting

Back to Parkinson Disease trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

University of Alabama at Birmingham, Birmingham, Alabama

Key details

Sponsor

University of Alabama at Birmingham

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Enrollment target

~140 participants

Started

April 2021

Primary completion

March 2027

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov